Pancreatic cancer biomarkers

Novel Biomarkers in Pancreatic Cancer | Semantic Scholar

Independentei, nr. Pancreatic cancer biomarkers, R.

Popescu, R. Albulescu, E. Raducan, A.

Also it is difficult to make the differential diagnosis with the pseudotumoral chronic pancreatitis, which has similar imagistic and clinical features, so surgery with hystopathologic diagnosis is needed. The preoperative staging of the pancreatic cancer has a limited accuracy max.

Raducan, S. Dima, L. Albulescu, I. Alina, P.

Account Options

Marius, L. Cruceru, E. Codorean, T.

Meghea, A. Murariu, E. Codorean, C.

Neagu, I. Popescu, Assessment of soluble angiogenic markers in pancreatic cancer, Biomarkers in Medicine, ; 2 5 Cristiana Pistol Tanase, S. Dima, M.

Mihai, E. Raducan, M.

Novel Biomarkers in Pancreatic Cancer

Nicolescu, L. Albulescu, B. Voiculescu, T.

Dumitrascu, L. Cruceru, M. Leabu, I. Popescu, M.

Hinescu, Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma, Journal of Molecular Histology, ; 40 1 Monica Neagu, C. Constantin, C.

Tanase, R. Tanase, C.

Boscornea, S. Tomas, R. Albulescu, Curcumin derivatives with potential biological activity, Revista de Chimie,60 1 Chivu M. Murariu, C.

Tanase, E. Codorean, Heavy metals contamination of commercial fish foodstuff — potential health risks on human consumers, Environmental Engineering and Management Journal,8 2 Florina Vasilescu, M.

Ceauşu, R.